A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers
Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers
Sponsor: Achieve Life Sciences
Terminated
It has been difficult to recruit participants meeting study entry criteria that are \>65 years of age and not for any safety reasons.
Listed as NCT03303911, this PHASE1/PHASE2 trial focuses on Smoking Cessation and remains terminated or withdrawn. Sponsored by Achieve Life Sciences, it has been updated 14 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE1_PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE1_PHASE2
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE1_PHASE2
-
Nov 2019 — Nov 2020 [monthly]
Terminated PHASE1_PHASE2
-
Jun 2019 — Nov 2019 [monthly]
Terminated PHASE1_PHASE2
-
Mar 2019 — Jun 2019 [monthly]
Terminated PHASE1_PHASE2
Status: Recruiting → Terminated
-
Jan 2019 — Mar 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2018 — Jan 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Achieve Life Sciences
For direct contact, visit the study record on ClinicalTrials.gov .